Bolt Biotherapeutics, Inc. — Form 8-K Summary
Reporting date: October 1, 2026; the report was signed October 6, 2026. The filing reports a material amendment to the company’s lease, not periodic operating results.
Business context and key financial terms
The amendment covers the company’s corporate office, laboratory and vivarium facilities at 800 and 900 Chesapeake Drive in Redwood City, California.
- The company paid the landlord $1.0 million upon entering the amendment.
- The company acknowledged that the landlord may draw the existing $1.5 million letter of credit in full.
- The lease expiration was accelerated to December 31, 2027, or earlier upon closing of a financing or other strategic transaction (“Corporate Transaction”).
- If a Corporate Transaction closes, the company must pay an additional $4.5 million termination payment.
- Effective October 1, 2026, ongoing rent and operating expense obligations for the premises are described as “not significant.”
- The company will continue its existing subleases for portions of the 800 Building and remit to the landlord 100% of sublease rent and common area maintenance payments received from each subtenant.
Financial results and changes
This 8-K does not provide revenue, profit, cash flow, margin, debt, liquidity or other period financial results. It also does not quantify the accounting impact of the lease amendment. Compared with the prior lease terms, the amendment brings forward the expiration date and establishes the payments and letter-of-credit draw right described above.
Outlook, contingencies and unusual items
The $4.5 million termination payment is contingent on closing a Corporate Transaction. The landlord’s right to draw the $1.5 million letter of credit is acknowledged, but the filing does not state whether a draw has occurred. The company is evaluating the accounting effects of the amendment. The amendment itself is not included in the filing; the company said it would file it as an exhibit to its 2026 Form 10-K.
Key facts for investors to verify
- Whether a financing or other Corporate Transaction closes and triggers the $4.5 million payment.
- Whether the landlord draws the letter of credit and the resulting effect on liquidity.
- The accounting treatment and recognized effects of the $1.0 million payment, letter of credit and conditional termination payment.
- How sublease receipts and related remittances affect cash flows, and the precise remaining lease obligations.
- The full terms in the Second Lease Amendment when filed with the 2026 Form 10-K.